Document Detail

Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics.
MedLine Citation:
PMID:  18929085     Owner:  NLM     Status:  MEDLINE    
The ideal management of women with epilepsy during pregnancy involves achieving an optimal balance between minimizing fetal exposure to the deleterious influences of both antiepileptic drugs (AEDs) and of seizures. Women with increased seizures during pregnancy tend to have subtherapeutic AED concentrations. Multiple physiological changes during pregnancy influence drug disposition, including increased volume of distribution, increased renal elimination, altered hepatic enzyme activity, and a decline in plasma protein concentrations. Many of the AEDs are characterized by significant increases in clearance during pregnancy. Studies performed thus far provide convincing findings for significant increases in the clearance of lamotrigine and phenytoin during pregnancy; other studies support that phenobarbital, oxcarbazepine, and levetiracetam clearances also most likely increase during pregnancy. Therapeutic drug monitoring of lamotrigine with adjustment of dosages during pregnancy to maintain that individual's target concentration has been shown to decrease the risk for increased seizure frequency. Reports of seizure worsening with decreased concentrations of other AEDs have been reported but not studied in similar formal protocols. Future studies of formal pharmacokinetic modeling of AEDs during pregnancy, with assessment of maternal and fetal/newborn consequences, could provide an important step toward achieving effective drug dosing to maintain therapeutic objectives for the mother but at the same time minimize fetal drug exposure.
Page B Pennell; Collin A Hovinga
Related Documents :
15853505 - Ropivacaine: a pharmacological review.
11318795 - Management of a pregnant patient with graves' disease complicated by thionamide-induced...
2589105 - Norwegian data on death due to overdose of antidepressants.
15610195 - Effects of seizures and their treatment on fetal brain.
24591935 - The assessment of nuchal translucency and serum markers for down syndrome screening wit...
21795485 - Second-trimester estimated fetal weight and discordance in twin pregnancies: associatio...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International review of neurobiology     Volume:  83     ISSN:  0074-7742     ISO Abbreviation:  Int. Rev. Neurobiol.     Publication Date:  2008  
Date Detail:
Created Date:  2008-10-20     Completed Date:  2009-01-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374740     Medline TA:  Int Rev Neurobiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  227-40     Citation Subset:  IM    
Emory Epilepsy Program, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / etiology*
Anticonvulsants / adverse effects*,  pharmacokinetics*
Epilepsy / drug therapy
Pregnancy Complications / metabolism*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Teratogenicity of antiepileptic drugs: role of pharmacogenomics.
Next Document:  Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure.